Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair.
Emboline has raised $20.0M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Emboline's investors include Trinity Capital, Shangbay Capital, SV Tech Ventures, Matrix Capital Management, Global Assets Investment.
Emboline is headquartered in Santa Cruz, United States.
Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair.
Emboline is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emboline — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/emboline. Accessed July 20, 2026.
VCBacked. (2026). Emboline — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/emboline
{{cite web |title=Emboline — Funding & Investors |url=https://www.vcbacked.co/company/emboline |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated